ORAGENICS, INC. Cost of Goods Sold (Deprecated 2018-01-31)
ORAGENICS, INC. (OGEN) reported Cost of Goods Sold (Deprecated 2018-01-31) of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-16.
Discontinued › Expense Statement
us-gaap:CostOfGoodsSold · last filed 2018-02-16
- ORAGENICS, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2016-12-31 was $0.00.
- ORAGENICS, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2016-09-30 was $0.00.
- ORAGENICS, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2016-06-30 was $0.00.
- ORAGENICS, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2016-03-31 was $89.95K, a 46.45% decline year-over-year.
- ORAGENICS, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2017 was $0.00.
- ORAGENICS, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2016 was $0.00.
- ORAGENICS, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- ORAGENICS, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2014 was $369.60K, a 7.64% increase from fiscal 2013.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 3 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 6 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 12 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-02-16 | |||||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $0.00 derived: sum of 2 quarters · filed 2018-02-16 | $0.00 derived: sum of 3 quarters · filed 2018-02-16 | $0.00 10-K · filed 2018-02-16 | ||||
| 2016-09-30 | $0.00 10-Q · filed 2016-11-14 | $0.00 derived: sum of 2 quarters · filed 2016-11-14 | $0.00 10-Q · filed 2016-11-14 | $89.95K derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2016-06-30 | $0.00 10-Q · filed 2016-08-15 | $0.00 10-Q · filed 2016-08-15 | $89.95K derived: sum of 3 quarters · filed 2017-02-27 | $89.95K derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2016-03-31 | $89.95K 10-Q · filed 2016-05-16 | $89.95K derived: sum of 2 quarters · filed 2017-02-27 | $89.95K derived: sum of 3 quarters · filed 2017-02-27 | $176.74K derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $0.00 derived: sum of 2 quarters · filed 2017-02-27 | $86.78K derived: sum of 3 quarters · filed 2017-02-27 | $0.00 10-K · filed 2017-02-27 | $481.74K 10-K · filed 2016-03-30 | |||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-14 | $134.59K 10-Q · filed 2015-11-06 | $86.78K derived: sum of 2 quarters · filed 2016-11-14 | $0.00 10-Q · filed 2016-11-14 | $389.37K 10-Q · filed 2015-11-06 | $345.30K derived: sum of 4 quarters · filed 2016-11-14 | ||
| 2015-06-30 | $0.00 10-Q · filed 2016-08-15 | $0.00 10-Q · filed 2016-08-15 | $254.78K 10-Q · filed 2015-08-07 | $345.30K derived: sum of 3 quarters · filed 2016-05-16 | $419.01K derived: sum of 4 quarters · filed 2016-05-16 | |||
| 2015-03-31 | $168.00K 10-Q · filed 2016-05-16 | $258.52K derived: sum of 2 quarters · filed 2016-05-16 | $332.23K derived: sum of 3 quarters · filed 2016-05-16 | $457.83K derived: sum of 4 quarters · filed 2016-05-16 | ||||
| 2014-12-31 | $90.52K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $164.23K derived: sum of 2 quarters · filed 2016-03-30 | $289.84K derived: sum of 3 quarters · filed 2016-03-30 | $369.60K 10-K · filed 2016-03-30 | ||||
| 2014-09-30 | $73.71K 10-Q · filed 2015-11-06 | $199.32K derived: sum of 2 quarters · filed 2015-11-06 | $279.08K 10-Q · filed 2015-11-06 | $358.44K derived: sum of 4 quarters · filed 2015-11-06 | ||||
| 2014-06-30 | $125.61K 10-Q · filed 2015-08-07 | $205.37K 10-Q · filed 2015-08-07 | $284.73K derived: sum of 3 quarters · filed 2015-08-07 | $398.11K derived: sum of 4 quarters · filed 2015-08-07 | ||||
| 2014-03-31 | $79.76K 10-Q · filed 2015-05-08 | $159.12K derived: sum of 2 quarters · filed 2015-05-08 | $272.51K derived: sum of 3 quarters · filed 2015-05-08 | $359.17K derived: sum of 4 quarters · filed 2015-05-08 | ||||
| 2013-12-31 | $79.36K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $192.75K derived: sum of 2 quarters · filed 2015-02-27 | $279.40K derived: sum of 3 quarters · filed 2015-02-27 | $343.35K 10-K · filed 2015-02-27 | ||||
| 2013-09-30 | $113.38K 10-Q · filed 2014-11-03 | $200.04K derived: sum of 2 quarters · filed 2014-11-03 | $263.99K 10-Q · filed 2014-11-03 | $667.92K derived: sum of 4 quarters · filed 2014-11-03 | ||||
| 2013-06-30 | $86.66K 10-Q · filed 2014-08-07 | $150.61K 10-Q · filed 2014-08-07 | $554.54K derived: sum of 3 quarters · filed 2014-08-07 | $718.60K derived: sum of 4 quarters · filed 2014-08-07 | ||||
| 2013-03-31 | $63.95K 10-Q · filed 2014-05-09 | $467.88K derived: sum of 2 quarters · filed 2014-05-09 | $631.94K derived: sum of 3 quarters · filed 2014-05-09 | $744.20K derived: sum of 4 quarters · filed 2014-05-09 | ||||
| 2012-12-31 | $403.94K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $567.99K derived: sum of 2 quarters · filed 2014-02-28 | $680.25K derived: sum of 3 quarters · filed 2014-02-28 | $878.46K 10-K · filed 2014-02-28 | ||||
| 2012-09-30 | $164.06K 10-Q · filed 2013-10-25 | $276.32K derived: sum of 2 quarters · filed 2013-10-25 | $474.53K 10-Q · filed 2013-10-25 | $629.95K derived: sum of 4 quarters · filed 2013-10-25 | ||||
| 2012-06-30 | $112.26K 10-Q · filed 2013-08-12 | $310.47K 10-Q · filed 2013-08-12 | $465.89K derived: sum of 3 quarters · filed 2013-08-12 | $600.30K derived: sum of 4 quarters · filed 2013-08-12 | ||||
| 2012-03-31 | $198.21K 10-Q · filed 2013-05-15 | $353.63K derived: sum of 2 quarters · filed 2013-05-15 | $488.04K derived: sum of 3 quarters · filed 2013-05-15 | $816.86K derived: sum of 4 quarters · filed 2013-05-15 | ||||
| 2011-12-31 | $155.42K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-26 | $289.83K derived: sum of 2 quarters · filed 2013-03-26 | $618.65K derived: sum of 3 quarters · filed 2013-03-26 | $713.63K 10-K · filed 2013-03-26 | ||||
| 2011-09-30 | $134.41K 10-Q · filed 2012-11-14 | $463.23K derived: sum of 2 quarters · filed 2012-11-14 | $558.21K 10-Q · filed 2012-11-14 | $996.42K derived: sum of 4 quarters · filed 2012-11-14 | ||||
| 2011-06-30 | $328.82K 10-Q · filed 2012-08-10 | $423.79K 10-Q · filed 2012-08-10 | $862.01K derived: sum of 3 quarters · filed 2012-08-10 | $1.01M derived: sum of 4 quarters · filed 2012-08-10 | ||||
| 2011-03-31 | $94.98K 10-Q · filed 2012-05-15 | $533.19K derived: sum of 2 quarters · filed 2012-05-15 | $680.45K derived: sum of 3 quarters · filed 2012-05-15 | $807.87K derived: sum of 4 quarters · filed 2012-05-15 | ||||
| 2010-12-31 | $438.21K derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-16 | $585.47K derived: sum of 2 quarters · filed 2012-04-16 | $712.89K derived: sum of 3 quarters · filed 2012-04-16 | $911.79K 10-K · filed 2012-04-16 | ||||
| 2010-09-30 | $147.26K 10-Q · filed 2011-11-14 | $274.68K derived: sum of 2 quarters · filed 2011-11-14 | $473.58K 10-Q · filed 2011-11-14 | |||||
| 2010-06-30 | $127.42K 10-Q · filed 2011-08-05 | $326.32K 10-Q · filed 2011-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |